References
- 1. Mármol I, Sánchez-de-Diego C, Dieste AP, Cerrada E, Yoldi MJR. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017. doi:10.3390/ijms1801019710.3390/ijms18010197529782828106826
- 2. Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016. doi:10.2147/CIA.S10928510.2147/CIA.S109285495836527486317
- 3. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017. doi:10.1136/gutjnl-2015-31091210.1136/gutjnl-2015-31091226818619
- 4. American Cancer Society. Cancer Facts & Figures 2016. Cancer Facts Fig 2016. 2016. doi:10.1097/01.NNR.0000289503.22414.7910.1097/01.NNR.0000289503.22414.7917846553
- 5. Ward HA, Murphy N, Weiderpass E, et al. Gallstones and incident colorectal cancer in a large pan-European cohort study. Int J Cancer. 2019. doi:10.1002/ijc.3209010.1002/ijc.3209030585640
- 6. Nogueira L, Freedman ND, Engels EA, Warren JL, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. Am J Epidemiol. 2014. doi:10.1093/aje/kwt32210.1093/aje/kwt322585608624470530
- 7. Chiong C, Cox MR, Eslick GD. Gallstone disease is associated with rectal cancer: A meta-analysis. Scand J Gastroenterol. 2012. doi:10.3109/00365521.2012.66053810.3109/00365521.2012.66053822369489
- 8. Chen Y, Wang Z. Cholelithiasis and cholecystectomy for colorectal cancer: a retrospective analysis. Zhonghua Wai Ke Za Zhi. 1998.
- 9. Rezasoltani S, Sadeghi A, Radinnia E, et al. The association between gut microbiota, cholesterol gallstones, and colorectal cancer. Gastroenterol Hepatol from Bed to Bench. 2019. doi:10.22037/ghfbb. v12i0.1823
- 10. Coccolini F, Catena F, Pisano M, et al. Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis. Int J Surg. 2015. doi:10.1016/j.ijsu.2015.04.08310.1016/j.ijsu.2015.04.08325958296
- 11. Cook JW, Kennaway EL, Kennaway NM. Production of tumours in mice by deoxycholic acid [10]. Nature. 1940. doi:10.1038/145627a010.1038/145627a0
- 12. Russell DW. The Enzymes, Regulation, and Genetics of Bile Acid Synthesis. Annu Rev Biochem. 2003. doi:10.1146/annurev.biochem.72.121801.16171210.1146/annurev.biochem.72.121801.16171212543708
- 13. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation. Curr Mol Med. 2012. doi:10.2174/15665241079223131210.2174/156652410792231312
- 14. Redinger RN. The coming of age of our understanding of the enterohepatic circulation of bile salts. Am J Surg. 2003. doi:10.1016/S0002-9610(02)01212-610.1016/S0002-9610(02)01212-6
- 15. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006. doi:10.1194/jlr.R500013-JLR20010.1194/jlr.R500013-JLR200
- 16. Nagengast FM, Grubben MJAL, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995. doi:10.1016/0959-8049(95)00216-610.1016/0959-8049(95)00216-6
- 17. Hill MJ. Bile flow and colon cancer. Mutat Res Genet Toxicol. 1990. doi:10.1016/0165-1110(90)90023-510.1016/0165-1110(90)90023-5
- 18. Magalhães B, Peleteiro B, Lunet N. Dietary patterns and colorectal cancer: Systematic review and meta-analysis. Eur J Cancer Prev. 2012. doi:10.1097/CEJ.0b013e328347224110.1097/CEJ.0b013e3283472241
- 19. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014. doi:10.1038/nrmicro334410.1038/nrmicro3344
- 20. Hofmann AF, Cravetto C, Molino G, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism. Gastroenterology. 1987. doi:10.1016/0016-5085(87)90430-610.1016/0016-5085(87)90430-6
- 21. Wilpart M. Co-mutagenicity of bile acids: Structure-activity relations. Eur J Cancer Prev. 1991. doi:10.1097/00008469-199110002-0000810.1097/00008469-199110002-000081842731
- 22. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009;50(8):1509-1520. doi:10.1194/jlr.R900007-JLR20010.1194/jlr.R900007-JLR200272404719346331
- 23. Chen X, Resh MD. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem. 2002. doi:10.1074/jbc.M20832720010.1074/jbc.M208327200
- 24. Payne C. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol. 2008. doi:10.2147/ceg.s434310.2147/CEG.S4343
- 25. Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009. doi:10.1194/jlr.R900007-JLR20010.1194/jlr.R900007-JLR200
- 26. Morotomi M, Guillem JG, LoGerfo P, Weinstein IB. Production of Diacylglycerol, an Activator of Protein Kinase C, by Human Intestinal Microflora. Cancer Res. 1990. J Lipid Res. 1997.
- 28. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res - Rev Mutat Res. 2005. doi:10.1016/j.mrrev.2004.08.00110.1016/j.mrrev.2004.08.001
- 29. Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012.
- 30. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006. doi:10.1016/S0140-6736(06)69044-210.1016/S0140-6736(06)69044-2
- 31. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver. 2012. doi:10.5009/gnl.2012.6.2.17210.5009/gnl.2012.6.2.172334315522570746
- 32. Sherlock S, Dooley J (James S. Diseases of the Liver and Biliary System. Blackwell Science; 2002.10.1002/9780470986820
- 33. Wang DQH, Afdhal NH. Genetic analysis of cholesterol gallstone formation: Searching for Lith (gallstone) genes. Curr Gastroenterol Rep. 2004. doi:10.1007/s11894-004-0042-110.1007/s11894-004-0042-115191694
- 34. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018. doi:10.1007/s11906-018-0812-z10.1007/s11906-018-0812-z586684029480368
- 35. Njeze GE. Gallstones. Niger J Surg Off Publ Niger Surg Res Soc. 2013;19(2):49. doi:10.4103/1117-6806.119236
- 36. Søreide K. Gallstone Disease and Cancer Risk: Finding the Bug in the System. Gastroenterology. 2017. doi:10.1053/j.gastro.2017.04.02810.1053/j.gastro.2017.04.02828461193
- 37. Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology. 1990. doi:10.1016/0016-5085(90)90839-S10.1016/0016-5085(90)90839-S
- 38. Chiong C, Cox MR, Eslick GD. Gallstones are associated with colonic adenoma: A meta-analysis. World J Surg. 2012. doi:10.1007/s00268-012-1646-510.1007/s00268-012-1646-522562454
- 39. Shabanzadeh DM, Sørensen LT, Jørgensen T. Association Between Screen-Detected Gallstone Disease and Cancer in a Cohort Study. Gastroenterology. 2017. doi:10.1053/j.gastro.2017.02.01310.1053/j.gastro.2017.02.01328238770
- 40. Mamianetti A, Garrido D, Carducci CN, Vescina MC. Fecal bile acid excretion profile in gallstone patients. Medicina (B Aires). 1999.
- 41. Herrera J, Amigo L, Husche C, et al. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients. Lipids Health Dis. 2009. doi:10.1186/1476-511X-8-5310.1186/1476-511X-8-53279749619995447
- 42. Keren N, Konikoff FM, Paitan Y, et al. Interactions between the intestinal microbiota and bile acids in gallstones patients. Environ Microbiol Rep. 2015. doi:10.1111/1758-2229.1231910.1111/1758-2229.1231926149537
- 43. Borzellino G, Cordiano C. Biliary Lithiasis: Basic Science, Current Diagnosis and Management.; 2008. doi:10.1007/978-88-470-0763-510.1007/978-88-470-0763-5
- 44. Shukla VK, Tiwari SC, Roy SK. Biliary bile acids in cholelithiasis and carcinoma of the gall bladder. Eur J Cancer Prev. 1993. doi:10.1097/00008469-199303000-0000810.1097/00008469-199303000-000088461866
- 45. Caddy GR, Tham TCK. Symptoms, diagnosis and endoscopic management of common bile duct stones. Best Pract Res Clin Gastroenterol. 2006. doi:10.1016/j.bpg.2006.03.00210.1016/j.bpg.2006.03.00217127190
- 46. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell. 2010. doi:10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025286662920303878
- 47. Gibney EJ. Asymptomatic gallstones. Br J Surg. 1990. doi:10.1002/bjs.180077040510.1002/bjs.18007704052187558
- 48. Tait N, Little JM. Fortnightly Review: The treatment of gall stones. BMJ. 1995;311(6997):99. doi:10.1136/bmj.311.6997.9910.1136/bmj.311.6997.9925501527613411
- 49. Di Ciaula A, Wang DQH, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am. 2010. doi:10.1016/j.gtc.2010.02.00510.1016/j.gtc.2010.02.005291545420478485
- 50. Barrasa JI, Olmo N, Lizarbe MA, Turnay J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol Vitr. 2013. doi:10.1016/j.tiv.2012.12.02010.1016/j.tiv.2012.12.02023274766
- 51. Tavani A, Rosato V, Di Palma F, et al. History of cholelithiasis and cancer risk in a network of case-control studies. Ann Oncol. 2012. doi:10.1093/annonc/mdr58110.1093/annonc/mdr58122231026
- 52. Clemente JC, Ursell LK, Parfrey LW, Knight R. The Impact of the Gut Microbiota on Human Health: An Integrative View - 1-s2.0-S0092867412001043-main.pdf. Cell. 2012. doi:10.1016/j.cell.2012.01.03510.1016/j.cell.2012.01.035505001122424233
- 53. Wu H, Tremaroli V, Bäckhed F. Linking Microbiota to Human Diseases: A Systems Biology Perspective. Trends Endocrinol Metab. 2015. doi:10.1016/j.tem.2015.09.01110.1016/j.tem.2015.09.01126555600
- 54. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011. doi:10.1371/journal.pone.001639310.1371/journal.pone.0016393302930621297998
- 55. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014. doi:10.1038/nature1282010.1038/nature12820395742824336217